No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial).
Zhang
Hai-tao
HT
Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Jia
Zhen-hua
ZH
Zhang
Jian
J
Ye
Zan-kai
ZK
Yang
Wei-xian
WX
Tian
Yue-qin
YQ
Jia
Xuan
X
Li
Wei
W
Wu
Yi-ling
YL
Yang
Yue-jin
YJ
D000208:Acute Disease; D000368:Aged; D003326:Coronary Circulation; D004311:Double-Blind Method; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008516:Medicine, Chinese Traditional; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D015899:Tomography, Emission-Computed, Single-Photon
D004365:Drugs, Chinese Herbal; C513941:tongxinluo